NBIS tracker

Independent. Not affiliated with, endorsed by, or sponsored by Nebius Group N.V.

NBIS
delayed quote
Back to dashboard

Funding and dilution

as of 24 Aug 2026 · Not calculable after the August 2026 refinancing

as of 30 Jun 2026 · Q2 2026 financial results, balance sheet

0M100M200Mshares 272M2024-122026-06

as of 30 Jun 2026 · Q2 2026 financial results, outstanding shares

August 2026 notes: coupon cash vs accretion

coupon plus annualised accretion$295M/yr
annual cash coupon$121M/yr

$174M a year is this tracker's straight-line principal-accretion estimate. It is not a company-reported annual expense.

as of 15 Aug 2026 · August 2026 convertible-note pricing

Balance sheet

Gross debtn/a
Cash$8.0B
Net debtn/a

Not shown because the August offering and partial exchange do not provide a complete post-transaction debt balance. The panel below is limited to the August 2026 offering.

Customer cash held, by quarter

$4.8B
2026-03
$6.0B
2026-06

August 2026 convertible offering

$3.5BAugust 2026 notes due 20300.5% · 15 Aug 2030
converts at $313.46 effective breakeven $345
$2.3BAugust 2026 notes due 20344.5% · 15 Aug 2034
converts at $324.65 effective breakeven $406

as of 30 Jun 2026 · August 2026 convertible-note pricing

ATM issuance ledger

period shares avg price gross src
2026-Q212,700,000$223.60$2.8BOpen source

as of 15 Jul 2026 · Asset-backed facility, July 2026

Updated 14 Oct 2026
Post on X